MetaCore PKU — Phenylketonuria (PKU) | Meta Healthcare

Medical nutritionMH-310

MetaCore PKU

Phenylketonuria (PKU)

CommercialStage 6 of 6

A medical nutrition product commercialised in the United Kingdom, designed to support the dietary management of phenylketonuria.

Indication: Dietary management of PKU
Patient population: Adolescent and adult patients
Regulatory status: Notified medical nutrition product (UK)
Geography: United Kingdom
Partner status: Wholly owned
Commercial note: UK adoption growing across specialist metabolic centres.

Milestones

UK launch2023
NHS framework adoption2024

Medical nutrition product for use under healthcare professional supervision.

Information on this page describes products and programmes under development or commercialised by Meta Healthcare. Statements about development status and regulatory progress are factual and do not constitute claims of efficacy, superiority or regulatory certainty. Programmes under evaluation are not approved for marketing in all listed territories. Medical nutrition and medical food products should be used under the supervision of a healthcare professional.